Evidence has indicated that the expression of proinflammatory cytokines (IL-12, IL-18, and TNF-γ) was reduced, while soluble inhibitory molecules (IL-10 and VEGF) were enhanced in GBM [24, 25]. The gene discussed is IL10; the disease is glioblastoma.